American International Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-50,466
Closed -$4.14M – 2639
2024
Q1
$4.14M Buy
50,466
+2,672
+6% +$119K 0.01% 799
2023
Q4
$889K Sell
47,794
-193
-0.4% -$2.52K ﹤0.01% 1364
2023
Q3
$531K Buy
47,987
+1,707
+4% +$24.4K ﹤0.01% 1565
2023
Q2
$750K Buy
+46,280
New +$970K ﹤0.01% 1402
2022
Q2
– Sell
-33,963
Closed -$102K – 3272
2022
Q1
$102K Sell
33,963
-2,391
-7% -$8.58K ﹤0.01% 2590
2021
Q4
$167K Sell
36,354
-1,087
-3% -$6.09K ﹤0.01% 2465
2021
Q3
$235K Sell
37,441
-890
-2% -$5.5K ﹤0.01% 2338
2021
Q2
$230K Buy
38,331
+116
+0.3% +$689 ﹤0.01% 2420
2021
Q1
$242K Buy
38,215
+101
+0.3% +$711 ﹤0.01% 2271
2020
Q4
$215K Sell
38,114
-1,093
-3% -$6.62K ﹤0.01% 2252
2020
Q3
$228K Sell
39,207
-892
-2% -$6.14K ﹤0.01% 2065
2020
Q2
$289K Buy
40,099
+1,684
+4% +$11.2K ﹤0.01% 1906
2020
Q1
$180K Sell
38,415
-2,219
-5% -$13.6K ﹤0.01% 1960
2019
Q4
$326K Sell
40,634
-342
-0.8% -$2.49K ﹤0.01% 1930
2019
Q3
$282K Sell
40,976
-285
-0.7% -$2.12K ﹤0.01% 1975
2019
Q2
$342K Buy
41,261
+2,303
+6% +$19.7K ﹤0.01% 1917
2019
Q1
$387K Sell
38,958
-526
-1% -$4.4K ﹤0.01% 1855
2018
Q4
$302K Buy
39,484
+5,081
+15% +$60.7K ﹤0.01% 1947
2018
Q3
$599K Buy
34,403
+6,036
+21% +$71.8K ﹤0.01% 1778
2018
Q2
$269K Buy
+28,367
New +$189K ﹤0.01% 2197

Other funds holding VKTX

American International Group's VKTX Position: Q2 2024 in Review

American International Group sold out of Viking Therapeutics (VKTX) in Q2 2024, closing a stake of 50,466 shares — an estimated $4.14M sold.

American International Group first reported a position in VKTX in Q2 2018 and held it in 20 quarters. The position peaked at $4.14M in Q1 2024. 387 funds tracked by Wall St. Rank hold VKTX as of Q2 2024.

  • American International Group reported no remaining Viking Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 50,466 Viking Therapeutics shares in Q2 2024, an estimated $4.14M.
  • American International Group first reported a position in Viking Therapeutics in Q2 2018 and held it in 20 quarters.
  • American International Group's Viking Therapeutics position peaked at $4.14M in Q1 2024.
  • 387 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.